Literature DB >> 25232034

Pathology of Natural Cases of Equine Endocrinopathic Laminitis Associated With Hyperinsulinemia.

N P Karikoski1, C M McGowan2, E R Singer2, K E Asplin3, R-M Tulamo4, J C Patterson-Kane5.   

Abstract

Laminitis in equids is a clinical syndrome usually associated with systemic disease. Endocrinopathies recently have been recognized as the most common cause of laminitis, with hyperinsulinemia playing a key role. Descriptions of laminitis-associated lesions have been confusing due to the wide range of experimental models used, failure of adequate clinical documentation for naturally occurring cases, lack of separate analysis of inflammatory and endocrinopathic laminitis, and uncertainty regarding normal morphological variation of lamellae. In this study, lamellar morphology and pathology were described in 14 laminitic horses and ponies that had hyperinsulinemia (>20 mIU/l), with reference to 25 age- and breed-matched controls. The type and severity of lesions noted had no correlation with reported clinical duration and in at least some cases must have preceded it. Lesions were largely localized abaxially within the lamellar tissue and included apoptotic cell death, as well as lamellar fusion, hyperplasia, and partial replacement with aberrant keratin containing nucleated debris and proteinaceous lakes. The lesions resulted in irregular margins between the inner horn and the lamellar tissue. Acute separation originated from the abaxial region, with minimal associated inflammation. Axially, epidermal lamellar tapering was the most frequent morphological observation. The lesions in these chronic cases of laminitis were similar to those described in some inflammatory laminitis models and contained features seen in developmental phases of hyperinsulinemic models. These findings support the theory that repeated episodes of subclinical laminitis occur prior to clinical presentation. In addition, the pathology does not include extensive basement membrane failure seen in some inflammatory models.
© The Author(s) 2014.

Entities:  

Keywords:  equine metabolic syndrome; horse; hyperinsulinemia; laminitis; pathology

Mesh:

Substances:

Year:  2014        PMID: 25232034     DOI: 10.1177/0300985814549212

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  20 in total

Review 1.  Equine metabolic syndrome.

Authors:  R Morgan; J Keen; C McGowan
Journal:  Vet Rec       Date:  2015-08-15       Impact factor: 2.695

2.  Evaluation of a Chemiluminescent Immunoassay for Measurement of Equine Insulin.

Authors:  H B Carslake; G L Pinchbeck; C M McGowan
Journal:  J Vet Intern Med       Date:  2017-01-26       Impact factor: 3.333

3.  Partial substitution, with their chelated complexes, of the inorganic zinc, copper and manganese in sow diets reduced the laminitic lesions in the claws and improved the morphometric characteristics of the hoof horn of sows from three Greek herds.

Authors:  Nikoleta Varagka; Marina Lisgara; Vassilis Skampardonis; Vassilis Psychas; Leonidas Leontides
Journal:  Porcine Health Manag       Date:  2016-09-07

4.  Effect of diet supplementation with chelated zinc, copper and manganese on hoof lesions of loose housed sows.

Authors:  Μarina Lisgara; Vassilis Skampardonis; Leonidas Leontides
Journal:  Porcine Health Manag       Date:  2016-02-10

5.  Mouldable, thermoplastic, glue-on frog-supportive shoes change hoof kinetics in normal and obese Shetland ponies.

Authors:  J Sleutjens; F M Serra Bragança; M W van Empelen; R E Ten Have; J de Zwaan; E Roelfsema; M Oosterlinck; W Back
Journal:  Equine Vet J       Date:  2018-02-12       Impact factor: 2.888

6.  The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies.

Authors:  Alexandra Meier; Dania Reiche; Melody de Laat; Christopher Pollitt; Donald Walsh; Martin Sillence
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

7.  The effect of insulin on equine lamellar basal epithelial cells mediated by the insulin-like growth factor-1 receptor.

Authors:  Courtnay L Baskerville; Subu Chockalingham; Patricia A Harris; Simon R Bailey
Journal:  PeerJ       Date:  2018-11-29       Impact factor: 2.984

8.  Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.

Authors:  Melody A de Laat; Dania B Reiche; Martin N Sillence; James M McGree
Journal:  J Vet Intern Med       Date:  2019-04-10       Impact factor: 3.333

9.  Association of sustained supraphysiologic hyperinsulinemia and inflammatory signaling within the digital lamellae in light-breed horses.

Authors:  Mauria R Watts; Olivia C Hegedus; Susan C Eades; James K Belknap; Teresa A Burns
Journal:  J Vet Intern Med       Date:  2019-03-25       Impact factor: 3.333

10.  A "modified Obel" method for the severity scoring of (endocrinopathic) equine laminitis.

Authors:  Alexandra Meier; Melody de Laat; Christopher Pollitt; Donald Walsh; James McGree; Dania B Reiche; Marcella von Salis-Soglio; Luke Wells-Smith; Ulrich Mengeler; Daniel Mesa Salas; Susanne Droegemueller; Martin N Sillence
Journal:  PeerJ       Date:  2019-06-07       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.